[Percutaneous correction of structural congenital heart diseases during the early puerperium. Experience of a center]. / Corrección percutánea de cardiopatías congénitas estructurales durante el puerperio temprano. Experiencia de un centro.
Arch Peru Cardiol Cir Cardiovasc
; 5(3): 137-142, 2024.
Article
em Es
| MEDLINE
| ID: mdl-39411019
ABSTRACT
Objetive Congenital heart diseases (CHD) can be found in pregnant women. Although cardiac interventions in the catheterization laboratory are considered safe and effective, it is preferable to wait 3-6 months after delivery to correct simple, uncomplicated CHD; however, this may result in follow-up losses. The objective is to present our experience in correcting CHD during the early puerperium (EP). Materials and methods:
All cases of pregnant women with CHD, including atrial septal defect (ASD), patent ductus arteriosus (PDA), and aortic coarctation (CoA) between 2017-2023, who underwent percutaneous defect correction during the EP were collected.Results:
Fifteen pregnant women were included, diagnosed with ASD (5), PDA (6), and CoA (4). Five patients (33.3%) were classified as WHO risk class IV; the procedure was successful in 80% of the cases, and only 1 patient presented complications.Conclusions:
In our experience, the closure of uncomplicated congenital defects during the EP did not present major complications and could be a treatment strategy to prevent follow-up losses after delivery in pregnant women with CHD.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
Es
Revista:
Arch Peru Cardiol Cir Cardiovasc
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
Peru